Back

FXIa inhibition

30 August 2024 (14:30 - 14:45)
Organised by: Logo
Congress Presentation Part of: Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon? Antiplatelet Drugs ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Diana A Gorog

National Heart and Lung Institute Imperial College, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Subcutaneous P2Y12 inhibition
Professor R. Storey (Sheffield, GB)
Slides Video
Presentation thumbnail
Subcutaneous GP IIb/IIIa inhibition
Professor J. ten Berg (Nieuwegein, NL)
Slides Video
Presentation thumbnail
Glycoprotein VI inhibition
Professor C. Christersson (Uppsala, SE)
Slides Video
Presentation thumbnail
Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon? - discussion
Video

Access the full session

Session thumbnail
Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon?
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Uncoupling ischaemic and bleeding complications: are new factor XI inhibitors too good to be true?
thumbnail
Congress Presentation
Shaping clinical practice and clinical trials
thumbnail
Congress Session
What does the future hold for factor XIa vs. factor Xa inhibitors in atrial fibrillation, acute coronary syndrome and stroke?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources